CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors

[1] Heimbach JK(2018)AASLD guidelines for the treatment of hepatocellular carcinoma Hepatology 67 358-380

[2] Kulik LM(2020)CEUS LI-RADS categories to distinguish hepatocellular carcinoma and non-hepatocellular carcinoma malignancies Radiology 296 E121-E122

[3] Finn RS(2016)LI-RADS-CEUS - proposal for a contrast-enhanced ultrasound algorithm for the diagnosis of hepatocellular carcinoma in high-risk populations Ultraschall Med 37 627-634

[4] Sirlin CB(2020)Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma Radiology 294 329-339

[5] Abecassis MM(2018)Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules J Hepatol 68 485-492

[6] Roberts LR(2010)World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective J Gastrointest Liver 19 311-317

[7] Giorgio A(2007)Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes Hepatol Res 37 S9-19

[8] De Luca M(2009)Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study JNCI-J Natl Cancer I 1348-1355

[9] Gatti P(2019)Global liver disease burdens and research trends: Analysis from a Chinese perspective J Hepatol 71 212-221

[10] Matteucci P(2016)Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84

[1] Heimbach JK(2018)AASLD guidelines for the treatment of hepatocellular carcinoma Hepatology 67 358-380

[2] Kulik LM(2020)CEUS LI-RADS categories to distinguish hepatocellular carcinoma and non-hepatocellular carcinoma malignancies Radiology 296 E121-E122

[3] Finn RS(2016)LI-RADS-CEUS - proposal for a contrast-enhanced ultrasound algorithm for the diagnosis of hepatocellular carcinoma in high-risk populations Ultraschall Med 37 627-634

[4] Sirlin CB(2020)Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma Radiology 294 329-339

[5] Abecassis MM(2018)Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules J Hepatol 68 485-492

[6] Roberts LR(2010)World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective J Gastrointest Liver 19 311-317

[7] Giorgio A(2007)Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes Hepatol Res 37 S9-19

[8] De Luca M(2009)Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study JNCI-J Natl Cancer I 1348-1355

[9] Gatti P(2019)Global liver disease burdens and research trends: Analysis from a Chinese perspective J Hepatol 71 212-221

[10] Matteucci P(2016)Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84